The immediate efficacy of inhaled nitric oxide treatment in preterm infants with acute respiratory failure during neonatal transport
- PMID: 31373038
- DOI: 10.1111/apa.14958
The immediate efficacy of inhaled nitric oxide treatment in preterm infants with acute respiratory failure during neonatal transport
Abstract
Aim: The aim of our review was to describe the clinical response to inhaled nitric oxide (iNO) in a series of preterm babies in respiratory failure during uplift transfers to a neonatal intensive care unit.
Methods: We performed a retrospective review of critical newborns with gestational age <34+0 weeks transferred from January 2013 to December 2018. Data were extracted from our Clinical Information System for transport. The primary measure of this review was to assess whether a significant improvement in the oxygenation saturation index (OSI) occurred following the use of iNO.
Results: Thirty preterm babies <34+0 weeks were included in our review. OSI, as a measure of oxygenation, did not statistically improve as an immediate response to iNO from referral to receiving hospital (17.1 vs 16.4; P = .7). We found that pH (7.15 vs 7.29; P = .004) and pCO2 (8.1 vs 6.3; P = .05) significantly improved probably based on ventilation management.
Conclusion: Following the recommendations of the American Academy of Paediatrics and other organizations, iNO should not routinely be used during the neonatal transfer of preterm babies <34+0 in respiratory failure. We need to conduct further studies to establish which selected preterm patients would benefit from being treated with iNO.
Keywords: neonatal transport; nitric oxide administration; premature infants; respiratory failure.
© 2019 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.
References
REFERENCES
-
- Huo Y, Aboud K, Kang H, Cutting LE, Bennett A. Inhaled nitric oxide therapy for pulmonary disorders of the term and preterm infant. Semin Perinatol. 2017;40(6):356-369.
-
- Askie LM, Ballard RA, Cutter GR, et al. Inhaled nitric oxide in preterm infants: an individual-patient data meta-analysis of randomized trials. Pediatrics. 2011;128(4):729-739.
-
- Kumar P. Use of inhaled nitric oxide in preterm infants. Pediatrics. 2014;133(1):164-170.
-
- Davidson L, Berkelhamer S. Bronchopulmonary dysplasia: chronic lung disease of infancy and long-term pulmonary outcomes. J Clin Med. 2017;6(1):4.
-
- Barrington KJ, Finer N, Pennaforte T. Inhaled nitric oxide for respiratory failure in preterm infants (Review). Cochrane Database Syst Rev. 2017;1:CD000509.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical